Concurrent Dexamethasone Limits The Clinical Benefit Of Immune Checkpoint Blockade In Glioblastoma

NEURO-ONCOLOGY（2020）

引用 95|浏览39

暂无评分

摘要

Our preclinical and clinical data indicate that concurrent dexamethasone therapy may be detrimental to immunotherapeutic approaches for patients with GBM.

查看译文

关键词

immune checkpoint blockade,concurrent dexamethasone

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要